Table 2.
Medication abortion pills sourcing and utilization
| Medication characteristics | One-week follow-up (n = 204) |
|
|---|---|---|
| Have you gotten the pills yet? | n = 204 | % |
| Yes | 202 | 99.0 |
| Yes, did not take b/c had a miscarriage | 1 | 0.5 |
| No, had a miscarriage prior to obtaining | 1 | 0.5 |
| How were the pills packaged? | n = 202 | % |
| Blister pack | 90 | 44.6 |
| Loose pills | 90 | 44.6 |
| Missing | 22 | 10.9 |
| Have you taken the pills yet? | n = 202 | % |
| Yes | 202 | 100.0 |
| Medication regimen | n = 202 | |
| Mifepristone and misoprostol | 107 | 53.0 |
| Misoprostol alone | 94 | 46.5 |
| Missing | 1 | 0.5 |
| Misoprostol route of administration | n = 370 | % |
| Sublingual | 339 | 91.6 |
| Buccal | 15 | 4.1 |
| Vaginal | 12 | 3.2 |
| Oral | 2 | 0.5 |
| Missing | 2 | 0.5 |
Data reported by 204 participants approximately one-week after contacting an accompaniment group for support with self-managed medication abortion